Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers
Authors:
- Belinda J. CridgeBCBelinda J. Cridge
- Lesley LarsenLLLesley Larsen
- Rhonda J. RosengrenRRRhonda J. Rosengren
Open Access
- 1 January 2013
- journal article
- Published by Herbert Publications PVT LTD in Oncology Discovery
- Vol. 1 (1) , 6
Abstract
Curcumin, a spice found in curry powder, is receiving considerable attention as a possible chemopreventative and chemotherapeutic. This review considers the evidence for the use of curcumin as a treatment for breast cancer,Keywords
This publication has 59 references indexed in Scilit:
- Breast cancer — one term, many entities?Journal of Clinical Investigation, 2011
- Heterogeneity in breast cancerJournal of Clinical Investigation, 2011
- Breast cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver AgreementJNCI: Journal of the National Cancer Institute, 2011
- Breast cancer molecular profiling with single sample predictors: a retrospective analysisThe Lancet Oncology, 2010
- WITHDRAWN: Deconstructing the molecular portraits of breast cancerMolecular Oncology, 2010
- ERα-negative and triple negative breast cancer: Molecular features and potential therapeutic approachesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Triple-negative breast cancer: current management and future optionsEuropean Journal of Cancer Supplements, 2009
- Refinement of breast cancer classification by molecular characterization of histological special typesThe Journal of Pathology, 2008
- Triple negative tumours: a critical reviewHistopathology, 2007